OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
52 hedge funds and large institutions have $23.6M invested in Orexigen Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 8 closing their positions.
Holders
52
Holders Change
-1
Holders Change %
-1.89%
% of All Funds
1.3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
16
Reduced
10
Closed
8
Calls
$1.79M
Puts
$1.36M
Net Calls
+$427K
Net Calls Change
+$733K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$1.93M |
| 2 |
GL
2
GLG LLC
New York
|
$861K |
| 3 |
3
BlackRock
New York
|
$752K |
| 4 |
FCMI
4
Foresite Capital Management III
Larkspur,
California
|
$1.31M |
| 5 |
EC
5
EcoR1 Capital
San Francisco,
California
|
$405K |
Top Sellers
| 1 |
CS
1
Credit Suisse
Zurich,
Switzerland
|
$808K |
| 2 |
2
Goldman Sachs
New York
|
$123K |
| 3 |
TSS
3
Two Sigma Securities
New York
|
$0 |
| 4 |
4
Millennium Management
New York
|
$0 |
| 5 |
5
Squarepoint
New York
|
$0 |
